A 39-year-old woman who received Sinovac and AstraZeneca Covid-19 shots died of brain swelling, doctors reported.
However, specialists have yet to determine if her death was linked to the mixed vaccines.
On Friday, Director for Emergency Health Hazard and Disease Control Dr. Chawetsan Namwat said the woman died on Tuesday in Prachuap Khiri Khan province.
She reportedly got two doses of the Sinovac vaccine after receiving an AstraZeneca dose as a booster shot.
Doctors said the woman had died one day after the second jab.
Preliminary autopsy revealed that a mass caused her brain to swell.
Blood in the brain out pressuring on the brain stem was determined as the cause of death.
“Experts will consider the autopsy report together with other evidence, including underlying conditions, before concluding whether the death had anything to do with the Covid-19 vaccinations,” Dr. Chawetsan explained.
He also said that Thailand had administered 14.29 million Covid-19 shots to date, and 231 vaccine recipients passed away afterwards.
Those figures suggest that there are 1.6 fatalities per 100,000 given doses.
Experts concluded that 122 of those deaths had nothing to do with inoculations.
However, in another 13 cases, it remained inconclusive if Covid-19 vaccines had been a determining factor, Dr. Chawetsan added.
The victim, a teacher, was found dead at her home in Muang district on Tuesday’s evening.
She reportedly suffered from hypertension and was inoculated with an AstraZeneca shot at Prachuapkhirikhan Hospital on Monday.
The woman received the first Sinovac’s shot three weeks earlier, on June 28.
According to officials reports, she had a fever and a headache on Monday. She also vomited many times a day after.
The teacher had run a maths tuition center that had been offering online services since January.
The Public Health Ministry and the Covid-19 Taskforce recently approved AstraZeneca vaccine’ use as the second dose for people who got a Sinovac jab.
The ministry said authorities had reached that conclusion after looking at several studies carried out by medical schools and other agencies.
“The results were satisfactory” the CSSA assistant spokeswoman Apisamai Srirangson stated earlier this month.
Besides, on July 12, Public Health Minister Anutin Charnvirakul said that the cross-formula shot would help recipients cope better with more contagious Covid-19 variants, such as the Delta strain.
